CD8A and neoplasm: This combinatorial strategy enhanced cytotoxicity against 4T1 breast cancer cells, increased CD4+ and CD8+ T-cell infiltration, induced immune memory, inhibited lung metastasis, and achieved sustained antitumor efficacy with the tumor volume reduced up to 70% (Figure 3) [58].